Two U.S. senators urged GlaxoSmithKline to do more about the ongoing shortage of Shingrix.

Inovio's South Korean partner GeneOne plans to start a phase 1/2 study in South Korea in the third quarter.

Here is some other vaccine news of note for the week.

Officials have vaccinated about 3,200 individuals in the Democratic Republic of Congo in response to a deadly outbreak.

Here is some other vaccine news of note for the week.

Patients might be hesitant to return for their second Shingrix dose if they experience side effects, according to doctors.

After reporting phase 2b results for FLU-v, SEEK Group CEO Gregory Stoloff said the program is ready for phase 3.

Merck is seeking FDA approval to expand Gardasil 9's use in women and men ages 27 to 45.